DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Lilly E.
Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results.
2012
https://investor.lilly.com/releasedetail.cfm?ReleaseID=703018

Download Bibliographical Data

Search in: